Okupe Oluyemi 4
4 · Hims & Hers Health, Inc. · Filed Jun 17, 2026
Research Summary
AI-generated summary of this filing
Hims & Hers (HIMS) CFO Okupe Oluyemi Receives RSU Shares
What Happened
- Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, had RSUs vest and convert into 71,616 shares on June 15, 2026. The issuer withheld 39,541 of those shares to cover tax withholding obligations at $30.17 per share, totaling $1,192,952. After withholding, roughly 32,075 net shares were issued to Oluyemi. Several line items in the filing show the RSU-to-share conversions and the withholding; entries with $0 reflect non-cash conversion/settlement of RSUs.
Key Details
- Transaction date: June 15, 2026; Form 4 filed June 17, 2026 (appears timely).
- RSU conversions reported: 71,616 shares (aggregate).
- Shares withheld for taxes: 39,541 shares at $30.17/share = $1,192,952 (tax withholding).
- Other line items: disposals shown at $0 (18,334; 22,988; 11,483; 18,811) represent the aggregate conversion/settlement mechanics of the RSUs (they sum to 71,616).
- Footnotes: RSUs convert 1:1 to Class A common stock; withholding performed by issuer to satisfy tax obligations; the various RSU grants are subject to 4-year service-based vesting schedules with initial vesting dates ranging from June 15, 2023 to June 15, 2026.
- Shares owned after the transaction: not specified in the provided excerpt.
Context
- This was a routine vesting/settlement of RSUs, not an open-market purchase or discretionary sale by the insider. The withholding of shares to cover taxes is a common cashless/net settlement practice and does not necessarily reflect a buy/sell decision by the insider. The filing shows conversion/exercise (derivative settlement) and tax-withholding transactions rather than an immediately executed market sale.
Insider Transaction Report
Form 4
Okupe Oluyemi
Chief Financial Officer
Transactions
- Exercise/Conversion
Class A Common Stock
[F1][F2]2026-06-15+71,616→ 335,683 total - Tax Payment
Class A Common Stock
[F3]2026-06-15$30.17/sh−39,541$1,192,952→ 296,142 total - Exercise/Conversion
Restricted Stock Unit
[F1][F4]2026-06-15−18,334→ 55,004 total→ Class A Common Stock (18,334 underlying) - Exercise/Conversion
Restricted Stock Unit
[F1][F5]2026-06-15−22,988→ 160,917 total→ Class A Common Stock (22,988 underlying) - Exercise/Conversion
Restricted Stock Unit
[F1][F6]2026-06-15−11,483→ 126,307 total→ Class A Common Stock (11,483 underlying) - Exercise/Conversion
Restricted Stock Unit
[F1][F7]2026-06-15−18,811→ 282,167 total→ Class A Common Stock (18,811 underlying)
Holdings
- 7,853(indirect: By Trust)
Class A Common Stock
Footnotes (7)
- [F1]The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
- [F2]Includes 1,113 shares acquired on May 20, 2026, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan.
- [F3]The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.
- [F4]The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2023.
- [F5]The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024.
- [F6]The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025.
- [F7]The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026.
Signature
/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe|2026-06-17